Biden’s New NIH Director Nominee, Who Was Selected by Fauci, Received $290 Million in Grant Funding from Pfizer

The ultimate red flag: Fauci personally advocated for Dr Monica Bertagnolli to become the nominee.

By Jordan Schachtel
Global Research, May 17, 2023
The Dossier 16 May 2023
Region:
Theme:

All Global Research articles can be read in 51 languages by activating the Translate Website button below the author’s name.

To receive Global Research’s Daily Newsletter (selected articles), click here.

Click the share button above to email/forward this article to your friends and colleagues. Follow us on Instagram and Twitter and subscribe to our Telegram Channel. Feel free to repost and share widely Global Research articles.

*** 

The White House has nominated a Pfizer-tied doctor to become the next director of the National Institutes of Health (NIH).

In a statement released by the White House, President Biden declared Dr. Monica Bertagnolli “a world-class physician-scientist whose vision and leadership will ensure NIH continues to be an engine of innovation to improve the health of the American people.”

The NIH is currently led by Lawrence Tabak, a Bill Gates stooge who replaced longtime NIH chief Francis Collins.

Collins resigned after emails surfaced that he and Anthony Fauci, among others, coordinated with other influential figures to silence doctors and scientists who opposed the covid hysteria narratives.

Dr Bertagnolli has received a stunning $290.8 million in research funding from Pfizer.

The Daily Signal, a project of the Heritage Foundation, reported that from 2015 through 2021, she “received more than 116 grants from Pfizer, totaling $290.8 million, making up 89% of her research grants.”

Anthony Fauci, who remains on salary at the NIH and has a taxpayer-funded U.S. Marshals security detail, told The Washington Post that he personally advocated for her selection as the next NIH director.

Bertagnolli has also received $17.4 million in grant funding from Janssen Research & Development LLC, a subsidiary of Johnson & Johnson.

The revolving door strikes again, now more in your face than ever before.

*

Note to readers: Please click the share button above. Follow us on Instagram and Twitter and subscribe to our Telegram Channel. Feel free to repost and share widely Global Research articles.
Articles by: Jordan Schachtel

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]

www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]